Cargando…
Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya
BACKGROUND: The fetal consequences of CMV infection have made it one of the most serious infections contracted during pregnancy. Despite the posed teratogenic risk during pregnancy, there is no national screening test for CMV infection is available during pregnancy in Kenya. Thus little is known on...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247150/ https://www.ncbi.nlm.nih.gov/pubmed/25392013 http://dx.doi.org/10.1186/1756-0500-7-794 |
_version_ | 1782346596996874240 |
---|---|
author | Maingi, Zakayo Nyamache, Anthony Kebira |
author_facet | Maingi, Zakayo Nyamache, Anthony Kebira |
author_sort | Maingi, Zakayo |
collection | PubMed |
description | BACKGROUND: The fetal consequences of CMV infection have made it one of the most serious infections contracted during pregnancy. Despite the posed teratogenic risk during pregnancy, there is no national screening test for CMV infection is available during pregnancy in Kenya. Thus little is known on its epidemiological data that is necessary for health planners and care providers. METHODS: A cross sectional study was conducted at Thika district level 5 hospital, Kenya to investigate seroprevalence of CMV infections and associated possible risk factors among pregnant women. Structured questionnaires were used to gather socio-demographic data and ELISA was used to detect CMV infections using IgG and IgM. RESULTS: Out of 260 pregnant women, 201 (77.3%) were CMV IgG 21(8.1%) CMV IgM being on acute stage of the disease. Marital status (OR = 3.7533, 95% CI =3.0231-6.9631, P < 0.0001), parity (OR = 3.7533, 95% CI = 3.0231-6.9631, P < 0.0001), and education (OR = 3.7533, 95% CI = 3.0231-6.9631, P < 0.0001), history of blood transfusion (OR = 0.0374, 95% CI = 0.00120-0.1168, OR = 0.3804) were found to significantly influence seropostivity in univariate analysis. CONCLUSION: The 88.4% CMV prevalence rate being detected among pregnant women calls for vaccine and routine screening for CMV infections and its associated risk factors in this kind of settings. |
format | Online Article Text |
id | pubmed-4247150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42471502014-11-29 Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya Maingi, Zakayo Nyamache, Anthony Kebira BMC Res Notes Research Article BACKGROUND: The fetal consequences of CMV infection have made it one of the most serious infections contracted during pregnancy. Despite the posed teratogenic risk during pregnancy, there is no national screening test for CMV infection is available during pregnancy in Kenya. Thus little is known on its epidemiological data that is necessary for health planners and care providers. METHODS: A cross sectional study was conducted at Thika district level 5 hospital, Kenya to investigate seroprevalence of CMV infections and associated possible risk factors among pregnant women. Structured questionnaires were used to gather socio-demographic data and ELISA was used to detect CMV infections using IgG and IgM. RESULTS: Out of 260 pregnant women, 201 (77.3%) were CMV IgG 21(8.1%) CMV IgM being on acute stage of the disease. Marital status (OR = 3.7533, 95% CI =3.0231-6.9631, P < 0.0001), parity (OR = 3.7533, 95% CI = 3.0231-6.9631, P < 0.0001), and education (OR = 3.7533, 95% CI = 3.0231-6.9631, P < 0.0001), history of blood transfusion (OR = 0.0374, 95% CI = 0.00120-0.1168, OR = 0.3804) were found to significantly influence seropostivity in univariate analysis. CONCLUSION: The 88.4% CMV prevalence rate being detected among pregnant women calls for vaccine and routine screening for CMV infections and its associated risk factors in this kind of settings. BioMed Central 2014-11-12 /pmc/articles/PMC4247150/ /pubmed/25392013 http://dx.doi.org/10.1186/1756-0500-7-794 Text en © Maingi and Nyamache; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Maingi, Zakayo Nyamache, Anthony Kebira Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya |
title | Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya |
title_full | Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya |
title_fullStr | Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya |
title_full_unstemmed | Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya |
title_short | Seroprevalence of Cytomegalo Virus (CMV) among pregnant women in Thika, Kenya |
title_sort | seroprevalence of cytomegalo virus (cmv) among pregnant women in thika, kenya |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247150/ https://www.ncbi.nlm.nih.gov/pubmed/25392013 http://dx.doi.org/10.1186/1756-0500-7-794 |
work_keys_str_mv | AT maingizakayo seroprevalenceofcytomegaloviruscmvamongpregnantwomeninthikakenya AT nyamacheanthonykebira seroprevalenceofcytomegaloviruscmvamongpregnantwomeninthikakenya |